- M.D., State University of New York, Stony Brook Health Science Center
- B.S., Biology, cum laude, Cornell University
- Internship/Residency, Pediatrics, Albany Medical Center
- Chief Resident/Clinical Instructor, Albany Medical Center
- Fellowship/Chief Fellow, Pediatrics Hematology/Oncology, Duke University Medical Center
- Fellowship, Pediatric Hematology/Oncology, Intensive Research Training, Duke University Medical Center
Department of Pediatrics
Department of Biochemistry
UVM Cancer Center
Cell, Molecular and Biomedical Sciences, Graduate Program Faculty
Areas of expertise
childhood cancer, AYA oncology, cancer biology, acute leukemia, epigenetics.
BIO
Jessica Heath is an Associate Professor of Pediatrics at the Larner College of Medicine. She is a pediatric hematologist-oncologist who treats children, adolescents and young adults with cancer and blood disorders. Dr. Heath is the Vice Chair of Research for the Department of Pediatrics and the Associate Director of Clinical and Translational Research at the UVM Cancer Center. Her own research focuses on understanding the molecular basis of high risk pediatric and adolescent leukemias, and using this knowledge to identify new treatments. Dr. Heath has a particular interest in rural cancer care delivery and conducts research and quality improvement in this space, assuring that new cancer treatments are available to all patients, regardless of where they live.
Courses
- Cancer Biology: The biological basis of childhood leukemia (A class in BIOC 6072)
Publications
Awards and Achievements
- Current Academic Appointments Years Institution Academic Title Department 2021
- Present University of Vermont Associate Professor Pediatrics 2021
- Present University of Vermont Associate Professor Biochemistry 2015
- Present University of Vermont Program Faculty Cellular, Molecular, and Biomedical Science (CMB) Graduate Program 2015
- Present University of Vermont Faculty Graduate Program Awards: Years Name of Honor/Award 2008 –2009
- 2009 Chief Resident, Pediatrics, Albany Medical Center
- 2011 – 2013 Chief Fellow, Pediatric Hematology/Oncology, Duke University
- 2015 American Society of Pediatric Hematology-Oncology Young Investigator Award
- 2011 – 2013, 2015 – 2017, 2021 - 2023 NIH Loan Repayment Award Recipient
- 2017 Pediatric Subspecialist of the Year Nominee
- 2020 Dean’s Excellence in Research: Rising Star New Investigator Award
- 2021 Jerold and Ingela Lucey Early Career Investigator Prize for Innovations in Infant or Child Health
- 2021 Pediatric Subspecialist of the Year
- 2022 UVM Health Network Group Junior Investigator of the Year
Bio
Jessica Heath is an Associate Professor of Pediatrics at the Larner College of Medicine. She is a pediatric hematologist-oncologist who treats children, adolescents and young adults with cancer and blood disorders. Dr. Heath is the Vice Chair of Research for the Department of Pediatrics and the Associate Director of Clinical and Translational Research at the UVM Cancer Center. Her own research focuses on understanding the molecular basis of high risk pediatric and adolescent leukemias, and using this knowledge to identify new treatments. Dr. Heath has a particular interest in rural cancer care delivery and conducts research and quality improvement in this space, assuring that new cancer treatments are available to all patients, regardless of where they live.
Courses
- Cancer Biology: The biological basis of childhood leukemia (A class in BIOC 6072)
Publications
Awards and Achievements
- Current Academic Appointments Years Institution Academic Title Department 2021
- Present University of Vermont Associate Professor Pediatrics 2021
- Present University of Vermont Associate Professor Biochemistry 2015
- Present University of Vermont Program Faculty Cellular, Molecular, and Biomedical Science (CMB) Graduate Program 2015
- Present University of Vermont Faculty Graduate Program Awards: Years Name of Honor/Award 2008 –2009
- 2009 Chief Resident, Pediatrics, Albany Medical Center
- 2011 – 2013 Chief Fellow, Pediatric Hematology/Oncology, Duke University
- 2015 American Society of Pediatric Hematology-Oncology Young Investigator Award
- 2011 – 2013, 2015 – 2017, 2021 - 2023 NIH Loan Repayment Award Recipient
- 2017 Pediatric Subspecialist of the Year Nominee
- 2020 Dean’s Excellence in Research: Rising Star New Investigator Award
- 2021 Jerold and Ingela Lucey Early Career Investigator Prize for Innovations in Infant or Child Health
- 2021 Pediatric Subspecialist of the Year
- 2022 UVM Health Network Group Junior Investigator of the Year
Select Publications
- Heath JL, Weiss JM, Lavau CP, Wechsler DS. Effects of iron depletion on CALM-AF10 leukemias. Exp Hematol. 2014 Dec;42(12):1022-1030.e1. doi: 10.1016/j.exphem.2014.08.004. Epub 2014 Sep 3. PubMed PMID: 25193880; PubMed Central PMCID: PMC4261044.
- Schjerven H, Ayongaba EF, Aghajanirefah A, McLaughlin J, Cheng D, Geng H, Boyd JR, Eggesbø LM, Lindeman I, Heath JL, Park E, Witte ON, Smale ST, Frietze S, Müschen M. Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1(+) pre-B ALL. J Exp Med. 2017 Mar 6;214(3):793-814. doi: 10.1084/jem.20160049. Epub 2017 Feb 11. PubMed PMID: 28190001; PubMed Central PMCID: PMC5339667.
- Aumann WK, Heath JL, Conway AE, Sze SK, Gupta VK, Kazi RR, Tope DR, Wechsler DS, Lavau CP. Fusion of the CRM1 nuclear export receptor to AF10 causes leukemia and transcriptional activation of HOXA genes. Leukemia. 2021 Mar;35(3):876-880. doi: 10.1038/s41375-020-0998-3. Epub 2020 Jul 30. PubMed PMID: 32733011; PubMed Central PMCID: PMC7854800.
- Fertal SA, Zaidi SK, Stein JL, Stein GS, Heath JL. CXCR4 Mediates Enhanced Cell Migration in CALM-AF10 Leukemia. Front Oncol. 2021;11:708915. doi: 10.3389/fonc.2021.708915. eCollection 2021. PubMed PMID: 35070954; PubMed Central PMCID: PMC8767107. Hesko C, Mittal N, Avutu V, Thomas SM, Heath JL, Roth ME. Creation of a quality improvement collaborative to address adolescent and young adult cancer clinical trial enrollment: ATAQI (AYA trial access quality initiative). Curr Probl Cancer. 2023 Dec;47(6):100898. doi: 10.1016/j.currproblcancer.2022.100898. Epub 2022 Sep 28. PubMed PMID: 36207194; PubMed Central PMCID: PMC11077416.